Artificial Intelligence in Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Artificial Intelligence in Diagnostics Market is segmented By Type (In Vitro Diagnostics, Diagnostic Imaging, and Other Types), Application (Cardiology, Oncology, Neurology, Obstetrics/ Gynecology, and Other Applications), End-User (Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

Artificial Intelligence in Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

AI in Diagnostics Market Size

artificial intelligence in diagnostics market
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 1.77 Billion
Market Size (2030) USD 7.41 Billion
CAGR (2025 - 2030) 33.14 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Global Artificial Intelligence in Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Artificial Intelligence in Diagnostics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

AI in Diagnostics Market Analysis

The Global Artificial Intelligence in Diagnostics Market size is estimated at USD 1.77 billion in 2025, and is expected to reach USD 7.41 billion by 2030, at a CAGR of 33.14% during the forecast period (2025-2030).

The COVID-19 pandemic has significantly impacted the healthcare system, particularly diagnostics. The lockdown measures worldwide decreased public mobility and impacted the diagnostic industry. Moreover, the COVID-19 pandemic not only affected the global economy but also greatly impacted the functioning of general hospital care for non-COVID-19 patients in hospitals across the globe. However, with the increasing demand for diagnostic imaging procedures globally, the demand for implementing artificial intelligence in diagnostics is also increasing. According to the article "Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives," published in April 2021, at different levels of the healthcare system, including diagnosis, artificial intelligence (AI) has been implemented. Particularly during the current pandemic, AI algorithms are crucial for the quick diagnosis of COVID-19 patients.

Additionally, AI tools were employed to handle the pandemic's depth and complexity, from diagnosis to drug development, disease transmission prediction, and population monitoring and surveillance. A study titled "The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic," published in the Journal of "Nature Public Health Emergency Collection" in April 2021, proposed a temporal step method, which includes presenting recent research investigations, examining how AI observes and acts on society and the healthcare system, and reporting various data types. Hence, the deployment of AI tools in diagnosing patients with SARS-CoV-2 played a substantial role throughout the pandemic phase, thereby augmenting the market growth.

Furthermore, factors such as increasing demand for AI tools in the medical imaging field and rising focus on reducing the workload of radiologists, government initiatives to increase the adoption of AI-based technologies, and growth in funding for AI-based start-ups are anticipated to bolster the growth of the market shortly.

Incorporating artificial intelligence into imaging devices may improve the diagnosis, which is expected to aid the overall market growth during the forecast period. For instance, the Journal of the American Medical Association article titled "An Artificial Intelligence-Based Chest X-ray Model on Human Nodule Detection Accuracy from a Multicenter Study," published in December 2021, reported that an artificial intelligence algorithm was associated with improved detection of pulmonary nodules on chest radiographs compared with unaided interpretation for different levels of detection difficulty and readers with different experience. The research articles stated that artificial intelligence could be a promising technology for medical imaging shortly.

Moreover, factors such as increasing funding for AI start-ups globally are increasing the demand for increasing incorporation of AI in the diagnostic imaging modalities. For instance, in March 2022, Qure.ai (Qure), a health-tech business raising USD 40 million in fundraising, employs artificial intelligence (AI) for medical imaging diagnostics. The company further declared that it would utilize the funding to broaden and improve its global presence, particularly in the United States and Europe, and accelerate the development of products for critical care and community diagnostics. Therefore, such fundraising is anticipated to contribute to market growth.

Thus, owing to the aforementioned factors, the market studied is anticipated to grow over the analysis period. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software is expected to restrain the market's growth.

AI in Diagnostics Industry Overview

The Artificial Intelligence in Diagnostics Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Siemens Healthineers, Nanox Imaging LTD (Zebra Medical Vision, Inc.), Riverain Technologies, Vuno, Inc., Aidoc, Neural Analytics, Imagen Technologies, Digital Diagnostics, Inc., GE Healthcare, AliveCor Inc., Enlitic, and InformAI.

AI in Diagnostics Market Leaders

  1. Nanox Imaging LTD (Zebra Medical Vision, Inc.)

  2. Riverain Technologies

  3. Aidoc

  4. Siemens Healthineers

  5. Vuno, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png
Need More Details on Market Players and Competiters?
Download PDF

AI in Diagnostics Market News

  • In June 2022, Bayer launched Calantic digital solutions to help address radiology industry challenges. The new platform includes apps to assist radiologists with workload management, lesion detection, and patient management. Bayer expanded the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI, and CT imaging.
  • In October 2021, Roche entered into an agreement with PathAI for pathology. Under the development and distribution agreement, the companies will jointly develop pathologists' embedded image analysis workflow.

AI in Diagnostics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand For AI Tools in the Medical Imaging Field and Rising Focus On Reducing the Workload of Radiologists
    • 4.2.2 Government Initiative to Increase the Adoption Of AI-Based Technologies
    • 4.2.3 Growth in Funding for AI-Based Start-Ups
  • 4.3 Market Restraints
    • 4.3.1 Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
    • 4.3.2 High Procurement Costs and Maintenance
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 In Vitro Diagnostics
    • 5.1.2 Diagnostic Imaging
    • 5.1.2.1 MRI
    • 5.1.2.2 CT
    • 5.1.2.3 X-rays
    • 5.1.2.4 Ultrasound
    • 5.1.2.5 Others
    • 5.1.3 Other Types
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Obstetrics/ Gynecology
    • 5.2.5 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Imaging Centers
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Siemens Healthineers
    • 6.1.2 Nanox Imaging LTD (Zebra Medical Vision, Inc.)
    • 6.1.3 Riverain Technologies
    • 6.1.4 Vuno, Inc.
    • 6.1.5 Aidoc
    • 6.1.6 Neural Analytics
    • 6.1.7 Imagen Technologies
    • 6.1.8 Digital Diagnostics, Inc.
    • 6.1.9 GE Healthcare
    • 6.1.10 AliveCor Inc.
    • 6.1.11 Enlitic
    • 6.1.12 InformAI
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Includes Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

AI in Diagnostics Industry Segmentation

Artificial intelligence (AI) in medicine uses algorithms and software to approximate human cognition in analyzing complex medical data. Specifically, AI in diagnostics assists healthcare providers in making appropriate treatment decisions for their patients. Artificial Intelligence in Diagnostics Market is segmented By Type (In Vitro Diagnostics, Diagnostic Imaging, and Other Types), Application (Cardiology, Oncology, Neurology, Obstetrics/ Gynecology, and Other Applications), End-User (Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market size and forecasts in value (USD million) for the above segments.

By Type In Vitro Diagnostics
Diagnostic Imaging MRI
CT
X-rays
Ultrasound
Others
Other Types
By Application Cardiology
Oncology
Neurology
Obstetrics/ Gynecology
Other Applications
By End-User Hospitals
Diagnostic Imaging Centers
Diagnostic Laboratories
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

AI in Diagnostics Market Research FAQs

How big is the Global Artificial Intelligence in Diagnostics Market?

The Global Artificial Intelligence in Diagnostics Market size is expected to reach USD 1.77 billion in 2025 and grow at a CAGR of 33.14% to reach USD 7.41 billion by 2030.

What is the current Global Artificial Intelligence in Diagnostics Market size?

In 2025, the Global Artificial Intelligence in Diagnostics Market size is expected to reach USD 1.77 billion.

Who are the key players in Global Artificial Intelligence in Diagnostics Market?

Nanox Imaging LTD (Zebra Medical Vision, Inc.), Riverain Technologies, Aidoc, Siemens Healthineers and Vuno, Inc. are the major companies operating in the Global Artificial Intelligence in Diagnostics Market.

Which is the fastest growing region in Global Artificial Intelligence in Diagnostics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Artificial Intelligence in Diagnostics Market?

In 2025, the North America accounts for the largest market share in Global Artificial Intelligence in Diagnostics Market.

What years does this Global Artificial Intelligence in Diagnostics Market cover, and what was the market size in 2024?

In 2024, the Global Artificial Intelligence in Diagnostics Market size was estimated at USD 1.18 billion. The report covers the Global Artificial Intelligence in Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Artificial Intelligence in Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Artificial Intelligence in Diagnostics Industry Report

Statistics for the 2025 Global Artificial Intelligence in Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Artificial Intelligence in Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Global Artificial Intelligence in Diagnostics Report Snapshots